Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Funny how no one will answer my questions.
As for your question, my answer is what I have posted in the past in regard to those thinking this will once again make those two epic runs that were based all on irrational exuberance on news that only the gamblers on the OTC will run with.
My answer: Gamblers will be gamblers. Thank you for being the only one being honest with the reasons why you have invested in this.
A question to ask yourself this weekend. How many successful publicly traded companies are there where the only employee is the CEO?
Expect Kraptain Kooster to dilute RGBP with a few more billion shares as he aint going to find any no dilutive or non toxic type of funding anytime soon. And his buddies at oncofakeapharma won't be able to give him a sweetheart deal again as their stock is in the crapper too.
Read it and weep:
Biotech in Cash Crunch: Only Best Science Likely to Get Funded—Can Alternative Open Network Models Cover the Gap?
Not only is the Kooster a business leader, he's also leverage leader as well!
Who knew?
Regen BioPharma "Leverages" Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio
Wow! You know that things are bad on a message board when I am the one that is first to post and comment on Dumbass Dave's PR release 5 hours ago about another billion dollar provisional patent he just filed!
This is going to be YUGE! Another billion dollars! KOOS IS A BUSINESS LEADER!
LOL ROFL PIMPL!
https://finance.yahoo.com/news/regen-biopharma-leverages-exosome-technologies-211000805.html
Just as suspected, another nothing burger of a week with a 10Q released showing more incompetence coming from David Rectum Koos.
As suspected, No one cent Friday yet again! The fud pucking misinformers can't get enough marks to but this scam stock!
SO let's look at this more closely.
David Rectum Koos paid Michael Dawald the equivalent of $300,000 (10,00,000 shares x .03 pps back on 10/10/22 )in $RGBPP stock to run Regen's facebook page.
That's quite a nice payment to do very little.
Too bad no one can actually investigate to see how those shares are being liquidated and if anyone, cough cough, is getting some of the funds given back...cough cough.... to the originator...cough cough.
$300,000 to consult about Facebook is quite suspect if you ask me. Not unlike paying your brother $117K in cash to do absolutely nothing.
Oh boy! Huge news! Rgbp on Facebook!
EX-10.3 4 ex10_3.htm EXHIBIT 10.3
Exhibit 10.3
Consultant's Fee Agreement
AGREEMENT ("Agreement") made this 20 day of October 2022, by and between Michael Dawald, (a private individual) hereinafter referred to as the "Consultant", and Regen BioPharma, Inc.(a Nevada corporation whose Series A Preferred shares currently trade over the OTC Pink Market under the symbol RG3PP) , hereinafter referred to as the "Company". Company and Consultant may be collectively referred to as "Parties" and individually referred to as "Party".
WHEREAS the Company desires to engage the Consultant perform certain tasks relating to the development, set up, marketing and promotion of the Company's business through social media( "Social Media Consulting")and
WHEREAS, Consultant, upon mutual execution of this Agreement will provide Social Media Consulting services to the Company
NOW, THEREFORE, it is agreed as follows:
1. Term.
The respective duties and obligations of the contracting parties shall be for a period of 12 months commencing on Oct 2J 2022.
2. Duties of Consultant.
Consultant shall assist the Company in customizing and managing the following:
Facebook Page for the Company Twitter Account for the Company
3. Compensation.
The Consultant shall receive a Consultant's Fee consisting of 10,000,000
shares of the Series A Preferred stock of the Company ("Consultant's Fee")
Company shall not be liable to the Consultant for any payment or reimbursement other than the Consultant's Fee.
4. Representations And Warranties Of Company.
a) Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent, approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.
(b) The execution, delivery and performance of this Agreement by Company does not and shall not constitute Company's breach of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument to which the Company is a party, or by which Company is or may be bound.
5. Representations And Warranties Of Consultant.
(a) Consultant has the requisite power and authority to enter into and perform his obligations under this Agreement without the consent, approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.
(b) The execution, delivery and performance of this Agreement by Consultant does not and shall not constitute Consultant's breach of any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument to which the Consultant is a party, or by which Company is or may be bound.
6. Restricted Securities Acknowledgment
Consultant acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act of 1933 shall constitute "restricted securities" as that term is defined in Rule 144 promulgated under the Securities Act of 1933, and shall contain the following restrictive legend:
"THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR SECURITIES LAWS OF ANY STATE AND MAY NOT 3E OFFERED, SOLD, ASSIGNED, ?LEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES T,AWS OR ?URSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COM?ANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEM?T FROM THE ACT OR SUCH LAWS."
7. Entire Agreement
This Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings, and re resentations between the parties.
8. Governing Law, Venue, Waiver Of Jury Trial
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys' fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
IN WITNESS WHEREOF, the parties have hereunto executed this Agreement on the 20th day of October, 2022.
By:
/s/ David Koos
David Koos, CEO
Regen BioPharma, Inc.
Consultant
/s/Michael Dawald
Michael Dawald
You are 100% correct about how difficult it is to bring a drug or therapy to market. I've explained this on the past on here but you know that the gamblers don't care or listen. It is why the vast majority have lost their behinds oh this.
Ok. But just keep this between us okay? I could get into trouble sharing this insider information.
I am told by my in the know source that Koos is looking to sell the IP to a big pharma for around the same price Kite got from Gilead.
The sticking point is that the big pharma wants P2 data first.
You know what won't recover, Koos' nose!
What are the odds that Koos can find any type of funding? I'd say .0047% he'll find funding.
But, I doubt he will find any legit funding. What ever "deal" he struck with fellow scam biotech Oncofakeapharma was a bogus one, imo. My speculation is that he showed the scamsters running that company how to utilize the OTC to fund their lifestyle and the "deal" for shares and $50K was how they paid him for his blueprint.
To date, Onco hasn't done squat other than release press releases about their plans to plan.
Let me be clear. I know naked shorting happens. I just don't believe it is happening to any significant degree, if at all, with this piss pot of a company at this particular moment. There are tons of other more lucrative stocks to short than this pile of crap
I'm really impressed on how Koos destroyed the naked shorters last week with his business leading 4th concall. That presentation was unlike anything I have ever seen from a biotech CEO. He should really teach a master class in it.
Can they be used to grow a new nose?
Meaningless stats that doesn’t mean squat to a sub penny otc stock. Everyone knows this.
Koos 4th failed con call will keep this right where it is supposed to be.
Lol @ thinking a short squeeze is going happen with $rgbp. More foolish hope for a sub penny stock.
Uh huh. I'll just break into some piggy banks to buy $RGBP lotto tickets where the odds of this taking off again is 1 chance in 1,000,000. Maybe more.
Buying into empty talk is what makes people believe in fool's gold and that is what the Kooster is good at.
Btw, what people heard is what he has always been saying for over a decade and he has nothing to show for it. I believe the same will be seen here.
I watched the first 2 mins and it was really difficult to watch. I was ROLLING when the lady running it was shocked that the kooster had not much to say in the introduction and told him as much. Koos is a master at rolling snake eyes.
Anyone stating he is a business leader is selling you a load of bull crap and pushing misinformation.
I am a better business leader drunk, high on meth, and running around naked wearing a wizard hat than the spittle riddled, rotting nose, mumbling and bumbling Deadbeat David Rectum Koos.
Let me guess, Kooster pretty much regurgitated the same thing he said in the last time he broadcasted his rotting nose back in December?
I wonder if Regen has a patent on a treatment for Syphilis?
Oh man! I can not wait for Koos to unload the mother of all great news during his 10 minute gab fest today!
What a way to start 2023 with Koos giving us the goods on how his company is going change how we treat cancer.
The stock will surely rip higher past 1 cent today on the earth shattering news he will bestow upon us.
Come on Koos! Release the KoosKraken!
Sorry I'm late to posting. Koos should do what CALA is doing. At least they are honest.
Pewwww WEEEE! New year and same ol' pps stagnation for the turd stock that goes by the symbol $RGBP.
It's been a year that we were told by the CEO we would get transparency from him by giving updates using social media (that didn't happen with any significance) and that he hired his unqualified brother to write a white paper and do some other insignificant things for a whopping (and odd number) of $117K. IF that isn't a sign of serious fraud then I don't know what is. If the white paper was ever written, we'll never know because it was never published. My guess is that $117K was a loan payback dressed up for services provided by the gynecologist brother. We have heard and seen nothing done by good Ol' Brian. Do you think Brian bought a nice Italian or German sports car with that $117K or did Brian invest that company in a true biotech other than RGBP.
And let us not forget that Brian didn't want $RGBP stock. Even he knows the stock isn't worthy having and that is saying something!
So sad that the sole employee and master scam artist, David Rectum Koos, still clings to the failed business model that he thought would bring him riches. The only thing it is bringing him now is a gurananteed $5000 per month in rent from one of his other companies. It's a nice scam to have.
Just wait until this pile of crapola becomes current! It will then fly to da moon!
Oh wait….it got curren and went right into the crapper.
As suspected once again, the mythical naked shorters have not been able to move the pps much at all. What does that mean? Mean that naked shorting being pushed on here is just a cover for the complete incompetency of David Rectum Koos.
And Regen is a StRoNg SELL!!!
LOL ROFL PIMPL!!!
https://www.barchart.com/stocks/quotes/RGBP
.00395! What a joke!
Lol rofl pimpl
We have been told that real progress was being made for over two years now and the pps completely tanked add more “progress” was being made.
Why do you think that happened?
Did the misinformation posted on here not pass the sniff test by the savvy otc gamblers?
GREAT POST !
AS USUAL 100% UNDENIABLE!!!
LOL ROFL PIMPL!!!
Wooooopty doo scooby doo!
Duracrap will most likely see the same fate as EVERYTHING else in Regen's pipeline of dusty IP.
That is he'll get some of the preclinical trial testing done. He'll release a press release, the stock will get pumped and then we'll hear NOTHING about it OR he'll submit the data to the FDA and get an incomplete response letter back from the FDA, just like he got for HemaX and dCellVax.
Oh, where is Dr. Kesari? Seems he no longer wants to take Koos' phone call
Where is Dyobio and the fast track? The only thing Koos has going is the FAT TRACK!
Where is Brian Koochie Koos and the white paper?
Where is the CSO and CFO?
Where is Lilly?
Where is the funding?
Where is Koos' nose?
ALL UNDENIABLE!!!!
LOL ROFL PIMPL!!!!
Here's an example of a deal that you will never ever see Koos, Regen, or any of his scam companies be part of.
The closest that Koos will ever get is that now inactive FDA IND for HemaXellerate. And remember why that went no where. He couldn't get anyone to fund it.
No one wants to give that fat bastard any funding.
https://finance.yahoo.com/news/2seventy-bio-announces-expanded-translational-141100727.html
UNDENIABLE!
100% misinformation as suspected! Kooster didn't update us at all about why the white paper was never written or, at least, published by his gynecologist brother!
Nor did Koos EVER publicly state what his brother did, if anything at all, for the $117K he paid him.
We know per SEC filings that he hired his brother to do certain things but Koos has NEVER EVER actually confirmed that Brian did anything that Koos said he was hired to do!
THAT'S A FACT!
Email him asking him where the white paper is. Let’s see if you get an answer because no one other than myself is asking about it.
I have. No response from the Kooster and that’s not surprising. But more importantly, no one should have to email him. He promised to keep his investors informed and he isn’t as usual.
He’s an otc scam artist ceo. He claims not to be being paid yet he has set up a nice $5000 a month rent check from one of his companies to his other company? Who is the person who cashes that’s check every month? You guessed it! David rectum Koos.